The global cryopreservation cell lines market is estimated to garner substantial revenue by growing at a CAGR of more than 20% over the forecast period, i.e., 2022 – 2031. The growth of the market is attributed primarily to a surge in focus of the healthcare companies on developing novel products for preserving various cells and tissues for research and use in medical applications. Additionally, growing use of advanced cryopreservation techniques by tissue engineering and bio banking facilities to maintain the functional characteristics of cells, is also anticipated to drive the market growth during the forecast period.
Get more information on this report: Request Sample PDF
In addition, increasing government initiatives for the preservation of stem cells is a major factor anticipated to fuel the market growth. For instance, New York Blood Center’s - National Cord Blood Program (NCBP), is the world's first and largest cord bank, that freezes and preserves cord blood units in liquid nitrogen freezers. It has recorded a collection of over 70,000 cord blood units and provided cord blood units for transplantation to over 5,300 recipients worldwide.
The global cryopreservation cell lines market is segmented by product type into cryoprotectant agents, cryogenic freezers, and others, out of which, the cryoprotectant agents segment is anticipated to hold the largest share over the forecast period. Factors such as growing number of government initiatives for the preservation of cells coupled with increasing number of biological research clinics is anticipated to propel the demand for cryopreservation cell lines products. Cryoprotectant agents such as propylene glycol, glycerol, and dimethyl sulfoxide (DMSO) are chemical compounds that are used to protect cells from damage during freeze-thaw. The most commonly used cryoprotectant is dimethyl sulfoxide (DMSO). However, this is not appropriate for all cell lines, where DMSO is used to induce differentiation. In such cases, an alternative cryoprotectant such as glycerol should be used.
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5,355.79, which grew from USD 3,515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Regionally, the cryopreservation cell lines market is segmented into five major regions, including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa region. The market in the North America region is estimated to witness noteworthy share over the forecast period on the back of increasing healthcare expenditure on research and development activities by pharmaceutical and other biotech companies. For instance, according to the World Bank data, current health expenditure (% of GDP) in North America increased from 12.2% in 2000 to 16.32% in 2019, growing at an average annual rate of 1.57%.
Further, increasing focus of market players on developing novel products for preserving various cells for research and use in medical settings is a major factor propelling the market growth in the region. For instance, Merck KGaA invested approximately USD 2.8 billion in 2020 in R&D. The company focused on both in-house research and external collaborations to launch new and innovative products.
Moreover, the market in the Asia Pacific region is expected to grow at the highest growth rate during the forecast period due to improved healthcare infrastructure and accelerating product management operations. Optimization of cryopreservation is the rapidly developing segment in this region and is likely to increase the demand for cryopreservation cell lines in Asia Pacific countries.
Get more information on this report: Request Sample PDF
The global cryopreservation cell lines market is further classified on the basis of region as follows:
North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Our in-depth analysis of the global cryopreservation cell lines market includes the following segments:
FREQUENTLY ASKED QUESTIONS
The major factors driving the growth of the cryopreservation cell lines market are increased R&D investments and new product launches by the major market players.
The market is anticipated to attain a significant CAGR of more than 20% over the forecast period, i.e., 2022-2031.
The major players operating in the market are Thermo Fisher Scientific Inc., Merck KGaA, BioLifeSolutions, HiMedia Laboratories Pvt. Ltd., and Cryologic Pty. Ltd, among others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company as well as the new products launched into the market by the company.
The cryopreservation cell lines market is segmented on the basis of product type and end user.
The cryoprotectant agents segment is anticipated to hold largest market size in value and is estimated to grow at a significant growth rate during the forecast period.
High maintenance cost is one of the prime factors affecting the market growth.
Asia Pacific region will provide more business opportunities for growth of cryopreservation cell lines market in future due to improved healthcare infrastructure and accelerating product management operations.
Select License Type
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization